One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Subscription Information
doi : 10.1016/S0022-202X(21)02644-0
Volume 142, Issue 2, February 2022, Page A2
Table of Contents
doi : 10.1016/S0022-202X(21)02645-2
Volume 142, Issue 2, February 2022, Pages A3-A5
Research Techniques Made Simple: Volume Scanning Electron Microscopy
RossLaws12David H.Steel3NeilRajan24
doi : 10.1016/j.jid.2021.10.020
Volume 142, Issue 2, February 2022, Pages 265-271.e1
SnapshotDx Quiz: February 2022
Amanda M.Walker1Benjamin F.Chong1
doi : 10.1016/j.jid.2021.11.021
Volume 142, Issue 2, February 2022, Pages e15-e20
Cells to Surgery Quiz: February 2022
KajalMadan1Rajiv I.Nijhawan1
doi : 10.1016/j.jid.2021.12.006
Volume 142, Issue 2, February 2022, Pages e21-e25
Messages from Mutant Desmosomes
Thomas M.Magin1MechthildHatzfeld2
doi : 10.1016/j.jid.2021.08.389
Volume 142, Issue 2, February 2022, Pages 272-274
Drug Repurposing Reveals mTOR Inhibition as a Promising Strategy for Epidermolysis Bullosa Simplex
HélèneRagot1AlainHovnanian123
doi : 10.1016/j.jid.2021.11.012
Volume 142, Issue 2, February 2022, Pages 275-278
Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma
EduardoNagore1AmayaVirós2RajivKumar345
doi : 10.1016/j.jid.2021.09.005
Volume 142, Issue 2, February 2022, Pages 279-281
Understanding and Harnessing Epithelial?Mesenchymal Interactions in the Development of Palmoplantar Identity
JerryTsai1MaryRostom1Luis A.Garza1
doi : 10.1016/j.jid.2021.06.016
Volume 142, Issue 2, February 2022, Pages 282-284
The Skin's Barrier: A Cryo-EM Based Overview of its Architecture and Stepwise Formation
LarsNorlén123MagnusLundborg45ChristianWennberg45AliNarangifard45BertilDaneholt25
doi : 10.1016/j.jid.2021.06.037
Volume 142, Issue 2, February 2022, Pages 285-292
MC1R Functions, Expression, and Implications for Targeted Therapy
StefaniaGuida1GabriellaGuida2Colin RonaldGoding3
doi : 10.1016/j.jid.2021.06.018
Volume 142, Issue 2, February 2022, Pages 293-302.e1
LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways
YingjianHuang1YuqianWang1YanWang2NingWang1QiqiDuan1ShengbangWang1MengLiu1Muhammad AhsanBilal1YanZheng1
doi : 10.1016/j.jid.2021.07.163
Volume 142, Issue 2, February 2022, Pages 303-313.e9
IRF6 Regulates the Delivery of E-Cadherin to the Plasma Membrane
AngeloAntiguas1Kris A.DeMali23MartineDunnwald1
doi : 10.1016/j.jid.2021.06.031
Volume 142, Issue 2, February 2022, Pages 314-322
Differential Pathomechanisms of Desmoglein 1 Transmembrane Domain Mutations in Skin Disease
Stephanie E.Zimmer12TakuyaTakeichi3Daniel E.Conway4AkiharuKubo5YasushiSuga6MasashiAkiyama3Andrew P.Kowalczyk17
doi : 10.1016/j.jid.2021.07.154
Volume 142, Issue 2, February 2022, Pages 323-332.e8
IL-22 Downregulates Peptidylarginine Deiminase-1 in Human Keratinocytes: Adding Another Piece to the IL-22 Puzzle in Epidermal Barrier Formation
AvinashPadhi12AnkitSrivastava134AbarajithaRamesh5MarcusEhrström6MichelSimon7EniköSonkoly189LivEidsmo1011PeterBergman212JosefinLysell19
doi : 10.1016/j.jid.2021.07.155
Volume 142, Issue 2, February 2022, Pages 333-342.e6
Measurement Properties of Patient-Reported Outcome Measures for Pruritus: An Updated Systematic Review
JanineTopp1ChristianApfelbacher2SonjaStänder3MatthiasAugustin1ChristineBlome1
doi : 10.1016/j.jid.2021.06.032
Volume 142, Issue 2, February 2022, Pages 343-354
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
StefanoPiaserico1PaoloGisondi2SimoneCazzaniga34SaraDi Leo5LuigiNaldi5
doi : 10.1016/j.jid.2021.04.036
Volume 142, Issue 2, February 2022, Pages 355-363.e7
Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review
TrishaKaundinya1UrosRakita2ArmaanGuraya3Donna MariaAbboud4EmilyCroce56Jacob P.Thyssen7AndrewAlexis8Jonathan I.Silverberg9
doi : 10.1016/j.jid.2021.06.033
Volume 142, Issue 2, February 2022, Pages 364-381
Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex
Gun HoLee12RamradaLekwuttikarn23ElidiaTafoya2MonicaMartin2Kavita Y.Sarin24Joyce M.Teng24
doi : 10.1016/j.jid.2021.07.170
Volume 142, Issue 2, February 2022, Pages 382-389
Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation
HongLi19CaiguoZhang19LiBian2HuiDeng13MelanieBlevins4GangwenHan25BinFan26ChunxiaYang17RuiZhao4WhitneyHigh1DavidNorris18MayumiFujita18Xiao-JingWang28MingxiaHuang1
doi : 10.1016/j.jid.2021.06.029
Volume 142, Issue 2, February 2022, Pages 390-401
ZFP36 Family Members Regulate the Proinflammatory Features of Psoriatic Dermal Fibroblasts
ChiaraAngiolilli12Emmerik F.A.Leijten12Cornelis P.J.Bekker12EllaEeftink1BarbaraGiovannone1Michel OldeNordkamp12Marlotvan der Wal1Judith L.Thijs3Sebastiaan J.Vastert14Femkevan Wijk1Timothy R.D.J.Radstake12Jorgvan Loosdregt1
doi : 10.1016/j.jid.2021.06.030
Volume 142, Issue 2, February 2022, Pages 402-413
Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by Fc?RI Aggregation but with Similar Dependence on the Extracellular Signal–Regulated Kinase 1/2 Module in Human Skin Mast Cells
ZhaoWang12KristinFranke1TorstenZuberbier1MagdaBabina1
doi : 10.1016/j.jid.2021.07.153
Volume 142, Issue 2, February 2022, Pages 414-424.e8
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3
HenriMontaudié12LauraSormani1BérengèreDadone-Montaudié34MarjorieHeim1NathalieCardot-Leccia3Meri K.Tulic1GuillaumeBeranger1Anne-SophieGay5DelphineDebayle5YannCheli6Jérémy H.Raymond789PierreSohier789ValériePetit789StéphaneRocchi1FranckGesbert789LionelLarue78910ThierryPasseron1210
doi : 10.1016/j.jid.2021.05.035
Volume 142, Issue 2, February 2022, Pages 425-434
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
CharléeNardin12CarolineLaheurte23EvePuzenat1LauraBoullerot23MélanieRamseyer2AmélieMarguier2MarionJacquin3YannGodet2FrançoisAubin125OlivierAdotevi2345
doi : 10.1016/j.jid.2021.07.160
Volume 142, Issue 2, February 2022, Pages 435-444
The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular Remodeling
GuangchaoXu16YaLuo16WenshuangWu26XiaoweiLiu16XinYu1YuBao1XiujingHe1JingYu1YannaLi1JiqiaoYang1RongjieZhang1ChuneYu1HongyingChen3JieXu4JianpingHu5JingJing17HubingShi17
doi : 10.1016/j.jid.2021.07.162
Volume 142, Issue 2, February 2022, Pages 445-458
Altered Skin and Gut Microbiome in Hidradenitis Suppurativa
SiobhánMcCarthy126MauriceBarrett136ShivashiniKirthi4PaolaPellanda13KlaraVlckova13Anne-MarieTobin4MichelleMurphy25FergusShanahan1Paul W.O’Toole13
doi : 10.1016/j.jid.2021.05.036
Volume 142, Issue 2, February 2022, Pages 459-468.e15
Deciphering the Role of Skin Surface Microbiome in Skin Health: An Integrative Multiomics Approach Reveals Three Distinct Metabolite?Microbe Clusters
Pierre-FrançoisRoux1ThierryOddos1GeorgiosStamatas1
doi : 10.1016/j.jid.2021.07.159
Volume 142, Issue 2, February 2022, Pages 469-479.e5
Increased Activation of Innate Immunity and Pro-Apoptotic CXCR3B in Normal-Appearing Skin on the Lesional Site of Patients with Segmental Vitiligo
ThierryPasseron12Valentina E.A.Malmqvst3HaneneBzioueche1SandrineMarchetti4StephaneRocchi1Meri K.Tulic1
doi : 10.1016/j.jid.2021.07.157
Volume 142, Issue 2, February 2022, Pages 480-483.e2
Barrier Function in Aging: Comments on Pilkington et al. “Inflammaging and the Skin”
Peter M.Elias12
doi : 10.1016/j.jid.2021.07.134
Volume 142, Issue 2, February 2022, Pages 483-484
Can Skin Aging Contribute to Systemic Inflammaging?
Suzanne M.Pilkington12SilviaBulfone-Paus13Christopher E.M.Griffiths124Rachel E.B.Watson124
doi : 10.1016/j.jid.2021.09.032
Volume 142, Issue 2, February 2022, Pages 484-485
Lack of Significant Association between Sex Hormone Concentrations and Atopic Dermatitis in Adolescents and Adults in Two Population-Based Studies
HannaKische1AnkeHannemann23CatharinaVoss1MatthiasNauck23HenryVölzke34LarsPieper15KatjaBeesdo-Baum15AndreasArnold6
doi : 10.1016/j.jid.2021.07.133
Volume 142, Issue 2, February 2022, Pages 486-489.e4
Transcriptomic Analysis of Blaschko-Linear Psoriasis Reveals Shared and Distinct Features with Psoriasis Vulgaris
AlexandrosOnoufriadis1UmarNiazi2KonstantinaDimitrakopoulou2JeremiasReich3ChrysanthiAinali4MariaPapanikolaou1EvangeliaKesidou1Chao-KaiHsu5MansoorSaqi2John A.McGrath17KristianReich67
doi : 10.1016/j.jid.2021.07.007
Volume 142, Issue 2, February 2022, Pages 489-493
Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol
MinakshiNihal1JianqiangWu1Connor J.Stonesifer2JayDaniels3JaehyukChoi3LarisaGeskin2Alain H.Rook4Gary S.Wood1
doi : 10.1016/j.jid.2021.06.034
Volume 142, Issue 2, February 2022, Pages 493-496.e7
